Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions

NCT06308679 is registered in ClinicalTrials.gov with Pharma Nueva as lead sponsor.

NCT NCT06308679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06308679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions
Lead sponsor
Pharma Nueva
Phase
Phase 1
Overall status
Unknown status
Start date
May 28, 2024
Completion date
June 7, 2024
Enrollment
28 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy vollunteer